HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$5.33
Day range
$5.20 - $5.49
Year range
$4.93 - $21.79
Market cap
200.84M USD
Avg Volume
266.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.95M | -97.94% |
Operating expense | 10.92M | 18.25% |
Net income | -43.10M | -178.32% |
Net profit margin | -2.21K | -3,903.84% |
Earnings per share | -1.04 | -167.10% |
EBITDA | -45.82M | -184.32% |
Effective tax rate | -0.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 354.01M | -24.64% |
Total assets | 448.78M | -22.88% |
Total liabilities | 69.28M | -54.43% |
Total equity | 379.50M | — |
Shares outstanding | 35.55M | — |
Price to book | 0.50 | — |
Return on assets | -25.05% | — |
Return on capital | -25.78% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -43.10M | -178.32% |
Cash from operations | -29.49M | -174.03% |
Cash from investing | 33.80M | 238.61% |
Cash from financing | 337.00K | -99.67% |
Net change in cash | 4.64M | -96.02% |
Free cash flow | -15.51M | -194.29% |
About
Founded
2016
Headquarters
Website
Employees
183
